Live Chat
21 May , 2013 15:43 IST

my Last 5 Scripts
Company BSE (Rs) % Chg
Hindalc 110.30 0.32
Tata Mo 293.15 3.06
Bhel 205.60 1.83
Tata St 308.65 11.78
State B 2361.10 2.16
Clear All Clear Last

   
Research
Sector Watch
Economy Watch
Glenmark Pharmaceutical Limited
shariahlogo
Quotes | Snapshot | Charts | Financials | Discussion Forum | BSE/NSE Notices |
AGM / AM | MF Holding | Research | Recent News | BSE/NSE Deals | Peer Group
 
 
Results Updates
QUOTES Live BSE Quote Live NSE Quote BSE Intraday Chart
Last Trade
  • Traded Date
  • Change
  • %Change
  • Open
  • High
  • Low
  • Volume
  • Best Bid
  • Best Offer
  • Previous
    Close
  • 52 Week
    High
  • 52 Week
    Low
  • Avg. Volume
573.75
  • 21-May-2013
    15:41
  • 0.45
  • 0.08
  • 573.25
  • 588.00
  • 569.10
  • 56,689
  • 0.00
  • 573.00
  • (20-May-2013)
    573.30
  • (20-May-2013)
    607.70
  • (21-May-2012)
    332.45
  • 56343
573.65
  • 21-May-2013
    15:31
  • 1.60
  • 0.28
  • 568.70
  • 588.00
  • 568.70
  • 522,032
  • 0.00
  • 0.00
  • (20-May-2013)
    572.05
  • (20-May-2013)
    609.00
  • (21-May-2012)
    307.35
  • 575133
NSE Intraday Chart
Sector: Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
Related Companies
  LTP(Last Traded Price) Change % Change
Glaxo Smithkline 2275.90 -5.15 -0.23
Cadila Healt 788.10 -19.60 -2.43
Key Market Stats
Mkt. Cap. (Rs. mn.) 137198.16
P/E 30.53
P/BV 14.08
Div (%) 0.00
Div Type
Del Vol/Total Vol (%) 0
Corporate Action
Dividend -
Bonus -
BSE
Book Closure Period
-
Purpose :
NSE
Book Closure Period
-
Purpose :
OTHER INDICATORS
  5 DMA 22 DMA 50 DMA 200 DMA
Price 565.72 516.49 500.87 465.48
Volume (in '000) 1112 631 633 597
  1 W 1 MO 3 MO 1 Year
Price rel to Sensex (%) 4.68 10.66 11.26 36.26
Price Appreciation (%) 7.51 17.68 14.56 70.60
Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer